Brief: Pasithea Therapeutics Announces Comprehensive Settlement Agreement With The Camac Group

Pasithea Therapeutics

12/12/2022 15:23

Dec 12 (Reuters) - Pasithea Therapeutics Corp  KTTA.O :
    * PASITHEA THERAPEUTICS ANNOUNCES COMPREHENSIVE SETTLEMENT
AGREEMENT WITH THE CAMAC GROUP
    * PASITHEA THERAPEUTICS CORP - PURSUANT TO AGREEMENT, CAMAC
GROUP
HAS AGREED TO A THREE-YEAR STANDSTILL PROVISION
    * PASITHEA THERAPEUTICS CORP - PURSUANT TO AGREEMENT PARTIES
HAVE
AGREED TO DISMISS WITH PREJUDICE PENDING DELAWARE LITIGATION
AGAINST CO, BOARD FILED BY CAMAC GROUP
    * PASITHEA THERAPEUTICS CORP - PURSUANT TO AGREEMENT CO
AGREED TO
PURCHASE ALL 3,205,282 SHARES OF CO'S COMMON STOCK HELD BY CAMAC
GROUP AT A PRICE OF $1.0003 PER SHARE

Source text for Eikon:  ID:nGNX29tHlV 
Further company coverage:  KTTA.O 
 ((Reuters.Briefs@thomsonreuters.com;))